curriculum vitae
SHORT CURRICULUM VITAE
Domenico Vittorio Delfino
DATE OF BIRTH: January 1, 1959
PLACE OF BIRTH: Reggio di Calabria, Italy
CITIZENSHIP: Italian
EDUCATION
1986 School of Medicine, University of Perugia, Perugia, Medical Degree
1986 School of Medicine, University of Perugia, Perugia, Medical Board
SCIENTIFIC WORK
1987-91 Italy, Family Medicine
1988-92 Univerity “La Sapienza”, Rome, Italy, “Experimental Medicine” Ph.D. Degree
1991-94 Department of Radiation Oncology, University of Pittsburgh Cancer Institute, Pittsburgh, PA, U.S.A., Research Associate
1994 23o meeting International Society of Experimental Hematology
Minneapolis, MN, U.S.A., Award
1994-95 Italy, Emergency Medicine
1995 Departiment of Clinical Medicine, Patology and Pharmacology; University of Perugia, Perugia, Italy, Assistant Professor
1998 Department of Radiation Oncology, University of Pittsburgh Cancer Institute, Pittsburgh, U.S.A., Visiting Professor
2001 Department of Clinical and Experimental Medicine, Section of Pharmacology, Toxicology and Chemotherapy, University of Perugia Medical School, Perugia, Italy; Associate Professor
2001 Department of Immunology and Microbiology, Albert Einstein College of Medicine, Yeshiva University, Bronx, New York, U.S.A., Visiting Professor
SCIENTIFIC MEMBER
Italian board of Clinical Medicine
International Society for Natural Immunity
International Society of Experimental Hematology
Italian Society of Pharmacology
Italian Society of Immunology
Italian Society of Hematology
Italian Society of Immunopharmacology
INTERNATIONAL PUBLICATIONS
1) G. Migliorati, L.Cannarile, F.D’Adamio, D. Delfino e C. Riccardi. Effetto di citochine sulla generazione di cellule NK e sulla resistenza contro cellule tumorali.
Journal of Chemotherapy, supplemento al n.2, 546, 1990. IF: 0.678
2) G. Migliorati, D. Delfino, F. D’Adamio, C. Riccardi. Immunopharmacology of natural reactivity: role of IFN-gamma and TNF-alpha in NK cell
generation from bone marrow precursors. Journal of Chemotherapy, vol.III, supplement n.3, June 1991. IF: 0.678
3) Graziella Migliorati, Paolo Cornaglia-Ferraris, Lorenza Cannarile, Domenico Delfino, Francesca D’Adamio, Flavio Mosci, Riccardo Stradi, Elisabetta Rossi, Guido Guidi and Carlo Riccardi. Effect of a new peptidyl-hypoxantine derivative on natural killer and antitumor activity. Cancer Detection and Prevention, volume 15, issue 4, 391, 1991. IF: 0.69
4) Domenico Delfino, Francesca D’Adamio, Graziella Migliorati, Carlo Riccardi. Growth of murine natural killer cells from bone marrow in vitro: Role of TNFa and IFNg. Int. J.Immunopharmac., vol.13, No.7, pp.943-954, 1991. IF: 0.531
5) Emira Ayroldi, Lorenza Cannarile, Francesca D’Adamio, Domenico Delfino, Graziella Migliorati, Carlo Riccardi. Long-Term cultures of mouse bone marrow cells: A model for studying the generation of natural killer cells. Nat Immun 1992;11:317-327. IF: 1.028
6) Fausto Vecchini, Domenico Delfino, Kenneth D. Patrene, Albert DeLeo, Lina Lu, Ronald B. Herberman, and Sallie S. Boggs. Generation of natural killer (NK) cells from long-term cultures of mouse bone marrow. Nat Immun 1993;12:1-16. IF: 1.028
7) Domenico V. Delfino, Kenneth D. Patrene, Albert B DeLeo, Rita DeLeo, Ronald B. Herberman, and Sallie S. Boggs. Role of CD44 in the development of NK cells from precursors in long-term cultures of mouse bone marrow. J.Immunol. 1994; 152:5171. IF: 7.166
8) Migliorati G., Nicoletti I., Delfino D., Maggioni A., Riccardi C. Pidotimod induce morte apoptotica ed inibisce l’attività proliferativa di cellule tumorali YAC-1 in vitro.
Drugs Exptl.Clin.Res. XIX (Suppl.) 1-7 (1993). IF: 0.536
9) G.Migliorati, D.Delfino, G.Nocentini, I.Nicoletti and C.Riccardi. Tumor Cell Death induced through the receptor for interleukin-2. Int. J. Immunopathol. Pharmacol. 1995; 8:161. IF: 0.339
10) D.V.Delfino, K.D.Patrene, A.DeLeo, R.DeLeo, R.B.Herberman and S.S.Boggs. Natural Killer Cell Precursors in the CD44neg/dim TCRneg Population of Mouse Bone Marrow.
Blood, 87:2394, 1996. IF: 8.372
11) Emira Ayroldi, Graziella Migliorati, Lorenza Cannarile, Rosalba Moraca, Domenico V. Delfino, and Carlo Riccardi. CD2 rescues T cells from T-cell receptor/CD3 apoptosis: a role for the Fas/Fas-L system. Blood. 89:3717, 1997. IF: 8.372
12) L.Cannarile, G.Venditti, E.Ayroldi, D.V.Delfino, G.Migliorati. Dexamethasone modulates IL-13 and IL-10 expression. Int. J. Immunopathol. Pharmacol. 10:175, 1997. IF: 0.339
13) Domenico V. Delfino, Enrica Lepri, Emira Ayroldi, Graziella Migliorati, Sallie S. Boggs, Carlo Riccardi. Suppression of Natural Killer Cell Differentiation by Activated T Lymphocytes in Long-term Cultures of Mouse Bone Marrow. Exp. Hematol. 26:2, 1998. IF: 3.467
14) Enrica Lepri, Domenico V. Delfino, Graziella Migliorati, Rosalba Moraca, Emira Ayroldi, Carlo Riccardi. Functional expression of Fas on mouse bone marrow stromal cells: up-regulation by TNF-α and IFN-γ. Exp.Hematol. 26:1202, 1998. IF: 3.467
15) Emira Ayroldi, Ornella Zollo, Lorenza Cannarile, Francesca D’Adamio, Ursula Grohmann, Domenico V. Delfino, and Carlo Riccardi. Interleukin-6 (IL-6) Prevents Activation-Induced Cell Death (AICD): Interleukin-2-Independent Inhibition of FAS/FASL Expression and Cell Death. Blood. 92:4212, 1998. IF: 8.372
16) Andrea Bartoli, Carlo Riccardi, Domenico V. Delfino. Corticosteroids as Stress-Induced Cell Defense Mechanism. Dev Brain Dysfunct. Vol. 10; pp. 475-481, 1998. IF: 0.372
17) Emira Ayroldi, Francesca D’Adamio, Ornella Zollo, Massimiliano Agostini, Rosalba Moraca, Lorenza Cannarile, Graziella Migliorati, Domenico V. Delfino, and Carlo Riccardi. Cloning and expression of a short Fas ligand: A new alternatively spliced product of the mouse Fas ligand gene. Blood. 94:1, 1999. IF: 8.372
17) Domenico V. Delfino, Barbara Di Marco, Cristina Marchetti, Andrea Bartoli, Emira Ayroldi, Stefano Bruscoli, Massimiliano Agostini, Stefania Spinicelli, Ornella Zollo, Graziella Migliorati. Effect of interleukin-2 on generation of natural killer cells: role of major histocompatibility complex class I in B6 and TAP-1-/- mice. J Chemother. 12:160-6, 2000. IF: 0.678
18) C. Riccardi, O. Zollo, G. Nocentini, S. Bruscoli, F. D’Adamio, L. Cannarile, D. Delfino, E. Ayroldi, G. Migliorati. Glucocorticoid hormones in the regulation of cell death. Thèrapie. 55:165-169, 2000. IF: 0.476
19) Giuseppe Nocentini, Andrea Bartoli, Simona Ronchetti, Linda Giunchi, Amelia Cupelli, Domenico Delfino, Graziella Migliorati, and Carlo Riccardi. Gene structure and chromosomal asssignment of mouse GITR, a member of the tumor necrosis factor/nerve growth factor receptor family. DNA and cell biology. 19:205-217, 2000. IF: 2.158
20) G. Nocentini, S. Ronchetti, A. Bartoli, S. Spinicelli, D. Delfino, L. Brunetti, G. Migliorati, and C. Riccardi. Identification of three novel mRNA splice variants of GITR. Cell death and Differ. 7:408-410, 2000. IF: 4.021
21) Domenico V. Delfino, Margarita Salcedo, Barbara Di Marco, Emira Ayroldi, Giuseppe Nocentini, Stefano Bruscoli, Luigi Brunetti, Hans-Gustaf Ljunggren and Carlo Riccardi. Differentiation of Ly49s-positive or -negative natural killer cells is inhibited by anti-H-2b monoclonal antibodies acting at the level of bone marrow progenitors from B6 mice. Cell Growth & Differentiation. 12:51-60, 2001. IF: 4.2
22) Massimiliano Agostini, Barbara Di Marco, Stefania Spinicelli, Stefano Bruscoli, Domenico V. Delfino. IL-2-driven natural killer cell generation: role of anti-H-2b monoclonal antibodies and stromal cells in controlling quantitative and repertoire changes. J Chemotherapy. 13:527-534, 2001. IF: 0.678
23) Massimiliano Agostini, Barbara Di Marco, Giuseppe Nocentini, Domenico V. Delfino. Oxidative stress and apoptosis in immune response. Int J Immunopathol Pharmacol. 15:157-164, 2002. IF: 3.927
24) Marchetti Maria Cristina, Barbara Di Marco, Maria Cristina Santini, Andrea Bartoli, Domenico V. Delfino, Carlo Riccardi. Dexamethasone-induced thymocytes apoptosis requires glucocorticoid receptor nuclear translocation but not mitochondrial membrane potential transition. Toxicol Lett. 139:175-180, 2003. IF: 2.224
25) Andrea Bartoli, Katia Fettucciari, Ilaria Fetriconi, Emanuela Rosati, Mauro Di Ianni, Antonio Tabilio, Domenico V. Delfino, Ruggero Rossi, Pierfrancesco Marconi. Effect of trichostatin a and 5′-azacytidine on transgene reactivation in U937 transduced cells. Pharmacol Res. 48:111-118, 2003. IF: 1.144
26) Domenico V. Delfino, Massimiliano Agostini, Stefania Spinicelli, Carlo Riccardi. Decrease of Bcl-xL and augmentation of thymocyte apoptosis in GILZ overexpressing transgenic mice. BLOOD. 104:4134-4141, 2004. IF: 10.120
27) Domenico V. Delfino, Massimiliano Agostani, Stefania Spinicelli, Carmine Vacca, Carlo Riccardi. Inhibited cell death, NF-kB activity and increased IL-10 in TCR-triggered thymocytes of transgenic mice overexpressing the glucocorticoid-induced protein GILZ. Int Immunopharmacol. 6/7:1126-1134, 2006. IF: 1,827
28) Domenico V. Delfino, Nicola Pozzesi, Stefania Gizzi, Massimiliano Agostini, Carmine Vacca, Lorenza Cannarile, Carlo Riccardi. IL-2 induces an altered CD4/CD8 ratio of splenic T lymphocytes from transgenic mice overexpressing the glucocorticoid-induced protein GILZ. J Chemother, 5:562-569, 2007. IF: 1,147
April 7, 2010 at 3:12 pm
Avrei piacere di essere aggiornato sul Suo lavoro in ambito oncologico per informare adeguatamente i nostri associati.
Grazie
SDP
Udine
April 7, 2010 at 4:49 pm
mi faccia sapere su che tipo di lavoro vuole essere aggiornato e come mai siete interessati al mio lavoro. Grazie, a presto!
April 7, 2010 at 4:58 pm
Salve, mi faccia sapere che tipo di aggiornamento le fa piacere avere. Mi farebbe piacere sapere come avete conosciuto il mio lavoro e come mai ne siete interessati. Grazie, a presto
Domenico Delfino
August 21, 2015 at 11:34 am
Salve, è possibile sapere i suoi recapiti?
September 26, 2016 at 11:18 am
Buongiorno
sono il Dottor Repaci, potrei avere i soui contatti per chiederele una Sua autorizzazione per l’uso di una sua figura che vorrei usare in un capitolo di un libro che sto scrivendo?
Grazie